Publications (original articles or review articles) published in 2015 from OUS - Section for head and neck oncology
10 publications found
Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
Acta Oncol, 54 (9), 1607-13
DOI 10.3109/0284186X.2015.1061690, PubMed 26213311
A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy
Cancer Nurs, 38 (6), 436-46
DOI 10.1097/NCC.0000000000000225, PubMed 25643005
Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy
Pain, 156 (5), 967-979
DOI 10.1097/j.pain.0000000000000142, PubMed 25719616
Pharmacist assessment of drug-related problems on an oncology ward
Eur. J. Hosp. Pharm., 22 (4), 194-197
DOI 10.1136/ejhpharm-2014-000510
Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
Springerplus, 4, 389
DOI 10.1186/s40064-015-1178-1, PubMed 26251773
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
BMC Res Notes, 8, 192
DOI 10.1186/s13104-015-1153-5, PubMed 25952979
Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
Eur J Surg Oncol, 41 (7), 920-6
DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010
Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
Childs Nerv Syst, 31 (12), 2283-90
DOI 10.1007/s00381-015-2792-5, PubMed 26174616
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
Radiother Oncol, 117 (1), 91-8
DOI 10.1016/j.radonc.2015.07.004, PubMed 26255764
Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Neuro Oncol, 17 (10), 1365-73
DOI 10.1093/neuonc/nov039, PubMed 25795305